Article info

Original research
Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial

Authors

  • Aldina Pivodic Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Helena Johansson Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, AustraliaSahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Lois EH Smith Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Chatarina Löfqvist Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenInstitute of Health Care Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Kerstin Albertsson-Wikland Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Staffan Nilsson Department of Mathematical Sciences, Chalmers University of Technology, Gothenburg, SwedenDepartment of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Ann Hellström Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Aldina Pivodic; aldina.pivodic{at}gu.se
View Full Text

Citation

Pivodic A, Johansson H, Smith LE, et al
Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial

Publication history

  • Received October 14, 2021
  • Accepted March 28, 2022
  • First published April 8, 2022.
Online issue publication 
April 08, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.